CALVIN DARDEN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CALVIN DARDEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CALVIN DARDEN. CALVIN DARDEN is Director in CARDINAL HEALTH INC ($CAH) and Director in TARGET CORP ($TGT) and Director in COCA-COLA EUROPEAN PARTNERS US, LLC ($CCE**) and Director in Aramark ($XXXX).
Latest Insider Trading Transactions of CALVIN DARDEN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XXXX, CAH, CCE**, TGT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 11 2021 | TGT | TARGET CORP | DARDEN CALVIN | Director | Grant | A | 0.00 | 1,004 | 0 | 36,497 | 35.5 K to 36.5 K (+2.83 %) |
Mar 05 2021 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 45 | 0 | 16,750 | 16.7 K to 16.8 K (+0.27 %) |
Feb 04 2021 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 4,518 | 0 | 16,704 | 12.2 K to 16.7 K (+37.08 %) |
Dec 10 2020 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 35 | 0 | 12,186 | 12.2 K to 12.2 K (+0.29 %) |
Nov 10 2020 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Grant | A | 0.00 | 3,339 | 0 | 39,616 | 36.3 K to 39.6 K (+9.20 %) |
Sep 03 2020 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 46 | 0 | 12,151 | 12.1 K to 12.2 K (+0.38 %) |
Jun 04 2020 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 50 | 0 | 12,105 | 12.1 K to 12.1 K (+0.41 %) |
Mar 13 2020 | TGT | TARGET CORP | DARDEN CALVIN | Director | Grant | A | 0.00 | 1,711 | 0 | 34,838 | 33.1 K to 34.8 K (+5.16 %) |
Mar 02 2020 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 37 | 0 | 12,055 | 12 K to 12.1 K (+0.31 %) |
Jan 31 2020 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 3,477 | 0 | 12,018 | 8.5 K to 12 K (+40.71 %) |
Jan 16 2020 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 115 | 0 | 6,114 | |
Dec 11 2019 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 22 | 0 | 8,541 | 8.5 K to 8.5 K (+0.26 %) |
Nov 13 2019 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Grant | A | 0.00 | 3,424 | 0 | 36,277 | 32.9 K to 36.3 K (+10.42 %) |
Oct 17 2019 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 122 | 0 | 6,441 | |
Sep 03 2019 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 23 | 0 | 8,519 | 8.5 K to 8.5 K (+0.27 %) |
Sep 03 2019 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 23 | 0 | 8,519 | 8.5 K to 8.5 K (+0.27 %) |
Jul 17 2019 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 120 | 0 | 6,471 | |
Jun 03 2019 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 27 | 0 | 8,496 | 8.5 K to 8.5 K (+0.32 %) |
Apr 17 2019 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 122 | 0 | 6,348 | |
Mar 15 2019 | TGT | TARGET CORP | DARDEN CALVIN | Director | Grant | A | 0.00 | 2,338 | 0 | 32,287 | 29.9 K to 32.3 K (+7.81 %) |
Mar 04 2019 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 31 | 0 | 8,469 | 8.4 K to 8.5 K (+0.37 %) |
Feb 01 2019 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 4,908 | 0 | 8,439 | 3.5 K to 8.4 K (+139.00 %) |
Jan 17 2019 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 119 | 0 | 6,222 | |
Dec 10 2018 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 10 | 0 | 3,531 | 3.5 K to 3.5 K (+0.28 %) |
Nov 13 2018 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Grant | A | 0.00 | 3,164 | 0 | 32,853 | 29.7 K to 32.9 K (+10.66 %) |
Oct 16 2018 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 106 | 0 | 6,091 | |
Sep 04 2018 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 9 | 0 | 3,520 | 3.5 K to 3.5 K (+0.26 %) |
Aug 09 2018 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 14 | 0 | 5,985 | |
Jul 16 2018 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 98 | 0 | 5,973 | |
Jun 04 2018 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 9 | 0 | 3,511 | 3.5 K to 3.5 K (+0.26 %) |
Apr 17 2018 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 82 | 0 | 5,859 | |
Mar 16 2018 | TGT | TARGET CORP | DARDEN CALVIN | Director | Grant | A | 0.00 | 2,538 | 0 | 28,951 | 26.4 K to 29 K (+9.61 %) |
Mar 05 2018 | XXXX | Aramark | DARDEN CALVIN | Director | Grant | A | 0.00 | 9 | 0 | 3,502 | 3.5 K to 3.5 K (+0.26 %) |
Jan 17 2018 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 69 | 0 | 5,760 | |
Nov 09 2017 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Grant | A | 0.00 | 2,623 | 0 | 29,689 | 27.1 K to 29.7 K (+9.69 %) |
Oct 17 2017 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 76 | 0 | 5,690 | |
Jul 17 2017 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 64 | 0 | 5,597 | |
Apr 17 2017 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 61 | 0 | 5,526 | |
Jan 17 2017 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 66 | 0 | 5,470 | |
Jan 13 2017 | TGT | TARGET CORP | DARDEN CALVIN | Director | Grant | A | 0.00 | 2,377 | 0 | 25,080 | 22.7 K to 25.1 K (+10.47 %) |
Nov 07 2016 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Grant | A | 0.00 | 2,447 | 0 | 27,066 | 24.6 K to 27.1 K (+9.94 %) |
Oct 18 2016 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 66 | 0 | 5,404 | |
Jul 18 2016 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 60 | 0 | 5,297 | |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | M | 0.00 | 18,593 | 0 | 0 | |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | M | 0.00 | 31,521 | 0 | 0 | |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | M | 0.00 | 4,876 | 0 | 0 | |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | M | 0.00 | 5,762 | 0 | 0 | |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | M | 0.00 | 11,160 | 0 | 0 | |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | M | 0.00 | 4,377 | 0 | 0 | |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | M | 0.00 | 5,208 | 0 | 0 | |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Sell | D | 0.00 | 81,497 | 0 | 0 | 81.5 K to 0 (-100.00 %) |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Buy | M | 0.00 | 18,593 | 0 | 81,497 | 62.9 K to 81.5 K (+29.56 %) |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Buy | M | 0.00 | 31,521 | 0 | 62,904 | 31.4 K to 62.9 K (+100.44 %) |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Buy | M | 0.00 | 4,876 | 0 | 31,383 | 26.5 K to 31.4 K (+18.40 %) |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Buy | M | 0.00 | 5,762 | 0 | 26,507 | 20.7 K to 26.5 K (+27.78 %) |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Buy | M | 0.00 | 11,160 | 0 | 20,745 | 9.6 K to 20.7 K (+116.43 %) |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Buy | M | 0.00 | 4,377 | 0 | 9,585 | 5.2 K to 9.6 K (+84.04 %) |
Jun 01 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Buy | M | 0.00 | 5,208 | 0 | 5,208 | 0 to 5.2 K |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Option Exercise | M | 33.80 | 6,391 | 216,016 | 0 | |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Option Exercise | M | 49.41 | 4,163 | 205,694 | 0 | |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Option Exercise | M | 55.46 | 4,109 | 227,885 | 0 | |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Option Exercise | M | 48.88 | 6,365 | 311,121 | 0 | |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Option Exercise | M | 58.13 | 3,957 | 230,020 | 0 | |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Option Exercise | M | 60.48 | 7,415 | 448,459 | 0 | |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Option Exercise | M | 48.89 | 4,705 | 230,027 | 0 | |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Sell | S | 67.02 | 37,105 | 2,486,896 | 22,134 | 59.2 K to 22.1 K (-62.64 %) |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Buy | M | 58.13 | 3,957 | 230,020 | 59,239 | 55.3 K to 59.2 K (+7.16 %) |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Buy | M | 55.46 | 4,109 | 227,885 | 55,282 | 51.2 K to 55.3 K (+8.03 %) |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Buy | M | 49.41 | 4,163 | 205,694 | 51,173 | 47 K to 51.2 K (+8.86 %) |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Buy | M | 48.89 | 4,705 | 230,027 | 47,010 | 42.3 K to 47 K (+11.12 %) |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Buy | M | 48.88 | 6,365 | 311,121 | 42,305 | 35.9 K to 42.3 K (+17.71 %) |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Buy | M | 33.80 | 6,391 | 216,016 | 35,940 | 29.5 K to 35.9 K (+21.63 %) |
May 23 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Buy | M | 60.48 | 7,415 | 448,459 | 29,549 | 22.1 K to 29.5 K (+33.50 %) |
Apr 04 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 591 | 0 | 18,593 | |
Apr 04 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 477 | 0 | 31,521 | |
Apr 18 2016 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 59 | 0 | 5,249 | |
Jan 19 2016 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 59 | 0 | 5,193 | |
Jan 15 2016 | TGT | TARGET CORP | DARDEN CALVIN | Director | Grant | A | 0.00 | 2,349 | 0 | 21,976 | 19.6 K to 22 K (+11.97 %) |
Jan 05 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 609 | 0 | 18,002 | |
Jan 05 2016 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 604 | 0 | 31,044 | |
Dec 07 2015 | TGT | TARGET CORP | DARDEN CALVIN | Director | Option Exercise | M | 53.98 | 3,706 | 200,050 | 0 | |
Dec 07 2015 | TGT | TARGET CORP | DARDEN CALVIN | Director | Sell | S | 72.91 | 3,706 | 270,207 | 19,471 | 23.2 K to 19.5 K (-15.99 %) |
Dec 07 2015 | TGT | TARGET CORP | DARDEN CALVIN | Director | Buy | M | 53.98 | 3,706 | 200,050 | 23,177 | 19.5 K to 23.2 K (+19.03 %) |
Nov 05 2015 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Grant | A | 0.00 | 1,848 | 0 | 24,619 | 22.8 K to 24.6 K (+8.12 %) |
Oct 15 2015 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 57 | 0 | 5,137 | |
Oct 01 2015 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 620 | 0 | 17,393 | |
Oct 01 2015 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 608 | 0 | 30,440 | |
Jul 15 2015 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 52 | 0 | 5,071 | |
Jul 14 2015 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | M | 15.30 | 12,399 | 189,705 | 0 | |
Jul 14 2015 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Sell | S | 45.00 | 12,399 | 557,955 | 0 | 12.4 K to 0 (-100.00 %) |
Jul 14 2015 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Buy | M | 15.30 | 12,399 | 189,705 | 12,399 | 0 to 12.4 K |
Jul 01 2015 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 690 | 0 | 16,773 | |
Jul 01 2015 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 668 | 0 | 29,832 | |
Apr 15 2015 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 49 | 0 | 5,019 | |
Apr 08 2015 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 678 | 0 | 16,083 | |
Apr 08 2015 | CCE** | COCA-COLA EUROPEAN ... | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 648 | 0 | 29,164 | |
Mar 04 2015 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Option Exercise | M | 28.80 | 9,801 | 282,269 | 0 | |
Mar 04 2015 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Sell | S | 87.85 | 9,801 | 861,018 | 22,771 | 32.6 K to 22.8 K (-30.09 %) |
Mar 04 2015 | CAH | CARDINAL HEALTH IN ... | DARDEN CALVIN | Director | Buy | M | 28.80 | 9,801 | 282,269 | 32,572 | 22.8 K to 32.6 K (+43.04 %) |
Jan 15 2004 | TGT | TARGET CORP | DARDEN CALVIN | Director | Option Exercise | A | 38.25 | 10,458 | 400,019 | 10,458 | |
Jan 15 2004 | TGT | TARGET CORP | DARDEN CALVIN | Director | Option Exercise | A | 38.25 | 10,458 | 400,019 | 10,458 | |
Oct 02 2003 | TGT | TARGET CORP | DARDEN CALVIN | Director | Option Exercise | A | 0.00 | 153 | 0 | 368 |
Page: 1